Table 1 Commercial serological assays and previously reported sensitivity and specificity
From: Sero-epidemiological assessment of Chlamydia trachomatis infection and sub-fertility in Samoan women
Assay name | Antigen | Study reference name | Sensitivity | Specificity | Detected group | Ref |
|---|---|---|---|---|---|---|
MEDACCT-IgG ELISA-plus MEDAC | MOMP | MEDAC MOMP | 55 % | 87 % | Women with infertility (n = 315) | [7] |
cHSP60-IgG ELISA MEDAC | cHSP60 | MEDAC cHSP60 | 69 % | 93 % | Women with TFI (n = 70) | [22] |
MEDAC IgG CT pELISA and cHSP60 IgG ELISA | Combination of both assays | MEDAC Infertile | [22] | |||
ANIlabsystems CT IgG | MOMP peptides | ANIlab | 91 % | 84 % | CT NAAT diagnosed infection and infertility (n = 303) | [16] |
CT IgA ELISA MEDAC | MOMP peptides | MEDAC IgA | NAAT diagnosed current infection | [23] | ||
C. pneumoniae-IgG-ELISA MEDAC | MOMP peptides | MEDAC Cpn | 91.3 % | 93.3 % | Current pneumonia and MIF positive status for C. pneumoniae | [24] |